Echo Therapeutics (ECTE) Gets Patent Allowance for Prelude SkinPrep System

June 20, 2012 7:57 AM EDT
Echo Therapeutics, Inc. (Nasdaq: ECTE), announced the receipt of a notice of allowance for a patent application covering its Prelude SkinPrep System and a notice of issuance for a patent covering its Symphony tCGM System.

Echo Therapeutics received notice that its U.S. Patent Application No. 10/792,862 entitled "Method and Apparatus for Enhancement of Transdermal Transport" has been allowed. Echo Therapeutics also received notice that its patent application entitled "Transdermal Analyte Monitoring Systems and Methods for Analyte Detection" issued as Russian Patent No. 2444980 and will expire in 2028 if all maintenance fees are timely paid.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, FDA

Add Your Comment